Mary-Jane Burkett

Ms. Burkett joined Miravo in 2012 and was promoted to CFO in September 2016. As CFO, Ms. Burkett’s transactional experience includes mergers and acquisitions, corporate restructuring and reorganization and financing arrangements. Ms. Burkett’s executive leadership responsibilities include Miravo’s financial operations, human resources and information technology functions.

Prior to her CFO role, Ms. Burkett held a number of finance roles with increasing responsibilities with Miravo, most recently as Corporate Controller, where she was instrumental in the carve-out of Crescita Therapeutics Inc., created on March 1, 2016 by way of a plan of arrangement that reorganized Nuvo Research Inc. into Miravo and Crescita.

Prior to joining Miravo, Ms. Burkett worked for PwC performing audit, internal audit and consulting work for its clients.

Ms. Burkett is a Chartered Professional Accountant and holds an Honours Bachelor of Business Administration degree from the Ivey Business School at the University of Western Ontario.